# Software Requirements Specification (SRS)
**Project:** CardioAI - Advanced ECG Interpretation System  
**Version:** 5.0.0  
**Date:** 2026-02-22  
**Compliance:** FDA 21 CFR Part 820, ISO 13485, ISO 14971, IEC 62304, HIPAA, GDPR, LGPD, ANVISA RDC 665

---

## 1. Introduction
### 1.1 Purpose
The purpose of this document is to specify the software requirements for CardioAI, a Software as a Medical Device (SaMD) designed to analyze 12-lead Electrocardiograms (ECGs) using Artificial Intelligence. It provides diagnostic support to clinicians by detecting arrhythmias, ischemia, and conduction abnormalities.

### 1.2 Scope
CardioAI receives digital ECG data (DICOM, HL7, JSON), processes it using ensemble deep learning models, and outputs a structured clinical report with diagnostic probabilities, risk stratification, and clinical recommendations. It is intended for use in hospital settings under the supervision of a cardiologist.

---

## 2. Clinical Use Cases

| ID | Use Case Name | Actor | Description |
| :--- | :--- | :--- | :--- |
| **UC-01** | **STEMI Detection** | ER Physician | System detects ST-elevation myocardial infarction patterns in real-time and triggers a "Code STEMI" alert with door-to-balloon time tracking. |
| **UC-02** | **Arrhythmia Screening** | Nurse / Tech | System analyzes routine ECGs for AFib, Flutter, or Heart Block, flagging abnormal traces for priority physician review. |
| **UC-03** | **Serial Comparison** | Cardiologist | System compares current ECG with patient's historical records to identify dynamic changes (e.g., new LBBB, evolving ischemia). |
| **UC-04** | **Risk Stratification** | Hospitalist | System calculates risk scores (TIMI, GRACE) and Bayesian probabilities to guide admission vs. discharge decisions for chest pain patients. |

---

## 3. Functional Requirements (FR)

### 3.1 Data Ingestion & Preprocessing
*   **FR-01:** The system shall accept 12-lead ECG data in DICOM (Supplement 30), HL7 aECG, and raw JSON formats.
*   **FR-02:** The system shall validate signal quality, detecting artifacts (EMG, baseline wander, powerline interference) and lead reversals.
*   **FR-03:** The system shall reject recordings with signal quality index (SQI) < 0.7 and notify the user to repeat the acquisition.

### 3.2 Diagnostic Analysis
*   **FR-04:** The system shall detect and classify at least 25 distinct cardiac rhythms and morphological abnormalities (see Appendix A).
*   **FR-05:** The system shall measure intervals (PR, QRS, QT, QTc) with an accuracy of ±5ms compared to gold standard.
*   **FR-06:** The system shall identify critical conditions (STEMI, VT, VF, Complete Heart Block) and assign a "CRITICAL" priority flag.
*   **FR-07:** The system shall perform serial comparison if prior ECGs are available, highlighting changes in ST segment (>1mm) or T-wave polarity.

### 3.3 Reporting & Output
*   **FR-08:** The system shall generate a DICOM Structured Report (SR) compliant with DICOM PS3.3.
*   **FR-09:** The system shall provide a visual heatmap overlay indicating the leads and segments contributing to the AI diagnosis (Explainability).
*   **FR-10:** The system shall output clinical recommendations based on AHA/ACC guidelines (e.g., "Activate Cath Lab").

---

## 4. Non-Functional Requirements (NFR)

### 4.1 Performance
*   **PERF-01:** **Latency:** The system shall process a standard 10-second 12-lead ECG and return results in < 2.0 seconds (95th percentile).
*   **PERF-02:** **Throughput:** The system shall support concurrent processing of at least 100 ECGs per minute per server node.
*   **PERF-03:** **Availability:** The system shall maintain 99.99% uptime during hospital operational hours.

### 4.2 Reliability & Accuracy
*   **REL-01:** **Sensitivity:** The system shall achieve ≥ 95% sensitivity for STEMI detection (validated against angiographic ground truth).
*   **REL-02:** **Specificity:** The system shall achieve ≥ 90% specificity for STEMI to minimize false catheterization lab activations.
*   **REL-03:** **AUC:** The system shall achieve an Area Under the Receiver Operating Characteristic (AUROC) curve > 0.99 for major arrhythmias.

### 4.3 Security & Privacy
*   **SEC-01:** **Encryption:** All Patient Health Information (PHI) shall be encrypted at rest (AES-256) and in transit (TLS 1.3).
*   **SEC-02:** **Authentication:** The system shall enforce Multi-Factor Authentication (MFA) for all clinical users.
*   **SEC-03:** **Audit Trail:** The system shall log all access, processing, and modification events in an immutable, digitally signed audit log (ISO 27001).
*   **SEC-04:** **Anonymization:** The system shall support de-identification of data for research purposes compliant with HIPAA Safe Harbor.

---

## 5. Regulatory Compliance Requirements

### 5.1 FDA (US) - Class II SaMD
*   **REG-01:** The system shall comply with **21 CFR Part 820** (Quality System Regulation).
*   **REG-02:** The system shall support **510(k)** submission requirements, including substantial equivalence demonstration.
*   **REG-03:** The system shall adhere to **IEC 62304** software lifecycle processes (Class B safety classification).

### 5.2 CE Mark (EU) - MDR
*   **REG-04:** The system shall comply with **EU MDR 2017/745** requirements for Class IIb medical devices.
*   **REG-05:** The system shall provide Clinical Evaluation Reports (CER) based on continuous post-market surveillance.

### 5.3 ANVISA (Brazil)
*   **REG-06:** The system shall comply with **RDC 665/2022** (Good Manufacturing Practices for Medical Devices).
*   **REG-07:** The system shall comply with **LGPD** (Lei Geral de Proteção de Dados) regarding patient data sovereignty.

---

## 6. Traceability Matrix

| Req ID | Description | Test Case ID | Risk ID | Module |
| :--- | :--- | :--- | :--- | :--- |
| **FR-06** | Critical Condition Detection | TC-DIAG-001 | RISK-01 (Missed STEMI) | `DiagnosticEngine` |
| **FR-03** | Signal Quality Rejection | TC-QUAL-005 | RISK-04 (Bad Data) | `QualityAssessor` |
| **PERF-01** | < 2s Latency | TC-PERF-010 | RISK-08 (Delay) | `InferenceEngine` |
| **SEC-03** | Immutable Audit Log | TC-SEC-022 | RISK-12 (Data Tampering) | `SecureAuditLogger` |
| **REL-01** | >95% Sensitivity | TC-VAL-100 | RISK-02 (False Negative) | `ValidationSuite` |

---

## 7. Acceptance Criteria

### 7.1 Clinical Validation
*   [ ] Validation dataset includes > 10,000 diverse cases (age, sex, ethnicity).
*   [ ] External validation on PhysioNet (MIT-BIH, PTB-XL) confirms metrics.
*   [ ] Clinical concordance study with 3 board-certified cardiologists shows Kappa > 0.8.

### 7.2 System Verification
*   [ ] All unit tests pass with > 90% code coverage.
*   [ ] Static code analysis (SonarQube) reveals no critical vulnerabilities.
*   [ ] Penetration testing confirms resistance to OWASP Top 10 threats.
*   [ ] Load testing confirms stability at 200% peak load for 24 hours.

---

**Approved By:**
*   Chief Medical Officer: ___________________
*   Lead Software Architect: ___________________
*   Regulatory Affairs Manager: ___________________
